QNCX·22053A107·US·equity·Healthcare - Biotechnology-13D/G
QNCX (QUINCE THERAPEUTICS INC) is held by 2 institutional investors as of Q1 2026. Largest holders: Woodline Partners LP ($527,280), MILLENNIUM MANAGEMENT LLC ($253,877), IEQ CAPITAL, LLC ($60,851). Net institutional sentiment: Bearish.
See how QNCX's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer